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5-Hydroxytryptamine (5-HT) Cellular Sequestration during
Chronic Exposure Delays 5-HT3 Receptor Resensitization due
to Its Subsequent Release*
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and Christopher N. Connolly1
From theMedical Research Institute, University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom
Background: Altered levels of 5-HT are thought to contribute to cognitive and gastrointestinal dysfunction.
Results: Intracellular accumulation of 5-HT leads to a prolonged loss of 5-HT3 receptor function.
Conclusion: 5-HT3 receptor desensitization is maintained by a chronic release of 5-HT.
Significance: Prolonged 5-HT3 receptor dysfunction may result from the clinical use of selective serotonin reuptake inhibitors
or pathologically raised 5-HT levels.
The serotonergic synapse is dynamically regulated by sero-
tonin (5-hydroxytryptamine (5-HT)) with elevated levels lead-
ing to the down-regulation of the serotonin transporter and a
variety of 5-HT receptors, including the 5-HT type-3 (5-HT3)
receptors. We report that recombinantly expressed 5-HT3
receptor binding sites are reduced by chronic exposure to 5-HT
(IC50 of 154.0 45.7 M, t1⁄2 28.6 min). This is confirmed for
5-HT3 receptor-induced contractions in the guinea pig ileum,
which are down-regulated after chronic, but not acute, exposure
to 5-HT. The loss of receptor function does not involve endocy-
tosis, and surface receptor levels are unaltered. The rate and
extent of down-regulation is potentiated by serotonin trans-
porter function (IC50 of 2.3  1.0 M, t1⁄2  3.4 min). Interest-
ingly, the level of 5-HT uptake correlates with the extent of
down-regulation. Using TX-114 extraction, we find that accu-
mulated 5-HT remains soluble and not membrane-bound. This
cytoplasmically sequestered 5-HT is readily releasable from
both COS-7 cells and the guinea pig ileum.Moreover, the 5-HT
level released is sufficient to prevent recovery from receptor
desensitization in the guinea pig ileum. Together, these findings
suggest the existence of a novel mechanism of down-regulation
where the chronic release of sequestered 5-HT prolongs recep-
tor desensitization.
The 5-hydroxytryptamine type-3 (5-HT3)2 receptor is a cat-
ionic ligand-gated ion channel that mediates fast excitatory
responses to serotonin (5-HT) in both the central and periph-
eral nervous systems. The 5-HT3 receptors belong to the Cys-
loop superfamily of ligand-gated ion channels that includes the
nicotinic acetylcholine, -aminobutyric acid type A and glycine
receptors (1). In humans there are five 5-HT3 receptor subtypes
(5-HT3A-E), with homomeric 5-HT3A and heteromeric
5-HT3AB being the most commonly expressed and best char-
acterized (2).
5-HT3 receptors are found in many regions of the central
nervous system including the hippocampus, entorhinal cortex,
and frontal cortex (3). However, the highest level of 5-HT found
in vivo is located in the enteric nervous system, where seroto-
nergic signaling through 5-HT3 receptors regulates important
physiological functions such as gut pacemaker activity, motor
activity, luminal sensing, and intestinal secretion (4, 5). To date
the therapeutic value of 5-HT3 receptor ligands is limited to the
use of antagonists in the control of chemotherapy-, radiother-
apy- and surgery-induced emesis (6, 7) and irritable bowel syn-
drome (8). Serotonergic neurons express the serotonin trans-
porter (SERT) (9), which terminates receptor signaling by the
efficient removal of extracellular 5-HT.
The serotonergic synapse is dynamically regulated, and ele-
vated 5-HThas been reported to cause a down-regulation of the
function of SERT (10, 11), 5-HT1A (12), 5-HT2A (13), 5-HT2C
(14), 5-HT4 (15), and 5-HT7 (16) receptors. In the case of 5-HT3
receptors, the long term down-regulation of receptor function/
expression has been reported after chronic exposure to ligands
(17–21). In the case of agonist-induced down-regulation, this
has been proposed to occur by receptor internalization (17, 18),
whereas antagonist-induced down-regulation is reported to
occur by prolonged binding (22, 23) rather than internalization
(24).
As discussed, elevated levels of 5-HT may alter serotonergic
signaling by disrupting the function or inducing the internal-
ization of many components of serotonergic neurotransmis-
sion. A number of pathophysiological disorders are character-
ized by elevated 5-HT levels, such as diarrhea-predominant
irritable bowel syndrome, chemo/radiotherapy, coronary
artery disease (25), and complex regional pain syndrome (26).
Similarly, the therapeutic use of selective serotonin reuptake
inhibitors or aWestern-style high fat/calorie diet are also char-
acterized by elevated 5-HT (27).
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We, therefore, sought to characterize how 5-HT3 receptors
are regulated by chronic exposure to 5-HT. In keeping with the
previous studies (17, 19, 21), we find that the chronic exposure
to high concentrations of 5-HT decreases the number of avail-
able 5-HT3 receptor binding sites without altering surface
receptor levels and is not blocked by inhibitors of endocytosis,
indicating that receptor internalization is not required for ago-
nist-induced down-regulation as observed for antagonist-in-
duced down-regulation (22). The 5-HT-induced down-regula-
tion is potentiated (67-fold) by SERT, highlighting a role for the
intracellular transport of 5-HT. Sequestered 5-HT is released
slowly from both COS-7 cells and guinea pig ileum. In support
of a role for the slow 5-HT release, the resensitization of 5-HT3
receptor-mediated contractions in the intact guinea pig ileum
is inhibited by low (5 M) 5-HT.
EXPERIMENTAL PROCEDURES
Chemical and Drug Sources—5-Hydroxytryptamine hydro-
chloride (5-HT, serotonin), nystatin, dynasore hydrate, brefel-
din A, filipin, TX-114, digitonin anti-HA/myc antibodies
(Sigma), 2-methyl-5-hydroxytryptamine hydrochloride (Toc-
ris, Bristol, UK), [3H]BRL-43964 ([3H]granisetron), and 5-
[3H]HT (PerkinElmer Life Sciences). Cell culture reagents,
Amplex UltraRed, and Alexa Fluor 488/568 conjugated anti-
mouse antibody (Invitrogen). Horseradish peroxidase conju-
gated anti-mouse antibody (GE Healthcare).
Cell Culture and Transfection—Simian COS-7 cells (ACC
CRL 1651) weremaintained in DMEM supplemented with 10%
fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate,
100 g/ml streptomycin, and 100 units/ml penicillin in an
atmosphere of 5% CO2 at 37 °C. Exponentially growing cells
were transfected by electroporation (400 V, ∞, 125 micro-
farads; Bio-Rad Gene Electropulser II). 10 g of DNA was
used per transfection (2 106 cells). Cells were analyzed 24–48 h
after transfection. Human 5-HT3A-myc was expressed from the
mammalian expression vector PRK5JD (28). Human SERT in
pcDNA3.1 was a kind gift from Beate Niesler (University of
Heidelberg, Heidelberg, Germany) and subcloned into
PRK5JD.
Radioligand Binding—[3H]Granisetron (specific binding 
83.1 Ci/mmol) binding was performed on intact COS-7 cells
cultured on poly-L-lysine-coated 96-well plates. Thesemethods
selectively measure cell surface 5-HT3 receptor binding sites
(22). Mock-transfected cells were used to determine the back-
ground. Cells were incubated in serum-free media (Opti-
MEM) test drugs for the indicated times at 37 °C. Cells were
then washed with warm binding buffer (10mMHEPES, 135mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) and incu-
bated in binding buffer at 37 °C for 10 min to remove excess
drug. Cells were washed with ice-cold binding buffer and incu-
bated in 3 nM [3H]granisetron (in binding buffer) for 120min on
ice. Excess radioligand was removed by washing with ice-cold
binding buffer. Receptor-bound radioligand was then eluted by
the addition of acidic saline (0.2 M acetic acid, 0.5 M NaCl, pH
2.5) for 30 min, added to scintillation mixture, and counted.
Background (mock) binding was subtracted, and specific bind-
ing was expressed as a percentage of untreated cells.
Cell Surface ELISA—Methods were as previously described
(22). Transiently transfected COS-7 cells were grown on poly-
L-lysine-coated 96-well plates. Cells were incubated in Opti-
MEM  5-HT at the indicated concentrations for 60 min at
37 °C. All subsequent solutions were made in PBS (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4, 1 mM
CaCl2, 1 mM MgCl2, pH 7.4) unless stated otherwise. After
experimental treatment, cells were fixed in ice-cold 3% parafor-
maldehyde (in PBS) for 15 min and then washed with PBS. To
reduce background signal, cells were incubated in 0.1 M glycine
for 60 min, washed, and then incubated in 3%H2O2 (to quench
endogenous peroxidase activity) for 5 min, washed again, and
then blocked for 60 min (5% FBS and 1% BSA in PBS). Primary
antibody (anti-HA; 12CA5) was incubated for 60 min and then
washed 3 times with block. Secondary antibody (sheep anti-
mouse HRP) diluted to 400 g/ml in block) was incubated for
60 min and subsequently washed 3 times in PBS. Cells were
then incubated with Amplex UltraRed (3 M) and H2O2 (740
M) for 60min in the dark, and the plate was read at excitation/
emission wavelengths of 530/590 nm. Background (mock) val-
ues were subtracted, and surface expression levels were pre-
sented as percentage of untreated cells.
Receptor Internalization Assay—COS7 cells were prelabeled
with mouse anti-HA antibodies (Sigma) (60 min, on ice),
washed, and incubated in the absence or presence of 5-HT (300
M) for 60 min at 37 °C. Cells were fixed in 3% paraformalde-
hyde (in PBS) and washed twice in 50 mM NH4Cl (in PBS) and
blocked (10% FBS, 0.5% BSA in PBS) for 30 min. Subsequent
washes and antibody dilutions were performed in PBS contain-
ing 10% FBS and 0.5% BSA. Surface receptors were detected
using anti-mouse Alexa Fluor 488 (Molecular Probes). Cells
were then permeabilized by the addition of 0.5% Triton X-100
(10 min), and the immunofluorescence protocol was repeated
from the NH4Cl step using anti-mouse Alexa Fluor 568 to
detect internalized receptors. Cells were examined using
a Hamamatsu ORCA-ER camera mounted on a DM-IRB
invertedmicroscope using Volocity software (PerkinElmer Life
Sciences).
5-[3H]HT Uptake Assay—COS-7 cells transfected with
human SERT or mock-transfected cells were grown on 24-well
plates. Cells were washed with uptake buffer (10 mM HEPES,
135 mMNaCl, 5 mM KCl, 10 mM glucose, 100 M ascorbic acid,
1 mM CaCl2, 1 mM MgCl2, pH 7.4) then incubated with
5-[3H]HT (as indicted) for 60 min at 37 °C. Cells were washed
twice with ice-cold buffer, solubilized with 1% TX-100, then
added to scintillation mixture and counted.
TX-114 Phase-partitioning of 5-[3H]HT—Transfected COS-7
cells were grown in 24-well plates. Cells were incubated with
Opti-MEM containing 10 M 5-HT (1:10 ratio 5-[3H]HT:cold
5-HT) for 60 min at 37 °C. Cells were washed (3 times) to
remove surface receptor-bound 5-HT. Cells were then solubi-
lized with 1% TX-114 (5 min on ice). Nuclei were pelleted by
centrifugation (14,000 rpm, 5 min, 4 °C), the post-nuclear
supernatantwaswarmed (5min, 37 °C) to precipitate the deter-
gent fraction-containing membranes and centrifuged (14,000
rpm, 5 min, 20 °C), and the soluble fraction (cytosol) was
removed and counted in scintillation fluid. The membrane
fraction was washed (1% TX-114) on ice to re-solubilize the
5-HT3 Receptor Desensitization by Chronic 5-HT Exposure
NOVEMBER 14, 2014•VOLUME 289•NUMBER 46 JOURNAL OF BIOLOGICAL CHEMISTRY 32021
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on January 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
detergent/membrane fraction. This process was repeated twice
to wash themembrane fraction before being counted. All inter-
mediate washes (soluble fraction) were pooled and counted.
Background counts (scintillation fluid only) were subtracted.
Measurement of Cytoplasmic 5-[3H]HT—Transfected COS-7
cells were grown in 24-well plates. Cells were incubated with
Opti-MEM containing 10 M 5-HT (1:10 ratio 5-[3H]HT:cold
5-HT) for 60 min at 37 °C. To remove surface receptor-bound
5-HT, cells were washed with warm binding buffer and then
once with ice-cold buffer. Cells were incubated with 100 g/ml
digitonin (diluted in binding buffer) for 5 min, and the buffer
was removed to count 5-[3H]HT associated with the cytoplas-
mic (released) contents. Cells were washed twice with ice-cold
binding buffer (and each wash counted) and then solubilized
with 1% TX-100 to count radioactivity remaining within the
cells.
Contractile Responses in the Guinea Pig Ileum—Male or
female Dunkin-Hartley guinea pigs (500–1000 g) were sacri-
ficed by cervical dislocation. The ileum was removed, and sec-
tions of tissue 15–25 mm in length were suspended in organ
baths containing 10 ml of air-bubbled Tyrode buffer (137 mM
NaCl, 2.7 mM KCl, 1.5 mM CaCl2, 1 mM MgCl2, 12 mM
NaHCO3, 0.4 mM NaH2PO4, 28 mM glucose, pH 7.4) main-
tained at 37 °C. Isotonic responses were measured using a
force transducer, and a resting tension of 1 g was applied.
Responses to a maximal concentration (50 M) of the 5-HT3
receptor agonist, 2-methyl 5-hydroxytrypamine (2-ME)
were measured to determine the basal 5HT3-mediated con-
traction of each tissue. Before receptor desensitization, tis-
sue was washed and allowed to recover (10 min, to ensure
receptor resensitization) before further stimulation. For
chronic exposure, 100 M 5-HT was applied for 60 min and
washed out (10 min), and subsequent 2-ME responses were
measured. To determine the specificity of the responses,
contractions evoked by acetylcholine (ACh) (1 M) were
monitored. In acute 5-HT exposure experiments, guinea pig
ileum tissue was exposed to 100 M 5-HT until receptors
desensitized (contractile response returned to base line)
before recover experiments. Recovery after 10 min (5 M
5-HT) was tested using 2-ME (50 M). All drugs (apart from
the experimental chronic 5HT treatment) were washed out
immediately after peak responses were observed. The peak
response to each drug addition was expressed as a percent-
age of the peak response at the beginning of the experiment.
5-HT Release Assay—Cos-7 cells were plated onto polyly-
sine-coated 96-well plates and grown for 24–48 h. Cells were
treated with 100 l of 300 M 5-HT (0.1% 5-[3H]HT, specific
activity  27.7 Ci/mmol) for 1 h at 37 °C in Opti-MEM and
washed twice with 100 l of warm Opti-MEM and left at 37 °C
for the times indicated. Samples (100 l) were placed into a
scintillation mixture, and radioactivity was counted. Segments
of adult guinea pig ileum were treated with 100 M 5-HT (0.1%
5-[3H]HT) for 1 h in air-bubbledTyrode buffer. After treatment
segments were briefly washed and stored in Tyrode buffer (1.5
ml) for the indicated times, and samples (100 l) were placed
into a scintillation mixture for counting.
RESULTS
Chronic Exposure to 5-HTDecreases Cell Surface 5-HT3 Recep-
tor Binding Sites in an Endocytosis-independent Manner—The
effect of chronic exposure of 5-HT3 receptors to 5-HT was
investigated in COS-7 cells expressing human 5-HT3A recep-
tors. Cells were incubated with 5-HT (300 M, 60 min, 37 °C,
followed by 10 min washout), and the remaining 5-HT3 recep-
tor binding sites were quantified by [3H]granisetron binding (3
nM, 120 min, 4 °C). Under these experimental conditions we
measured only cell surface receptor binding sites (22). We
found that the chronic exposure to 5-HT causes a significant
decrease in receptor binding (p 0.001; paired t test; n 5) to
20.5 4.0% of untreated cells (Fig. 1A).
A potential mechanism for 5-HT-mediated 5-HT3 loss of
function is the promotion of receptor internalization (17, 18).
To investigate this we used inhibitors of clathrin- and caveolin-
mediated endocytosis. 5-HT3A-expressing cells were preincu-
bated (60 min, 37 °C) with either dynasore (80 M) a clathrin
inhibitor, nystatin (21 M), a caveolin inhibitor, or both
together. Cells were then exposed to 5-HT (300 M) in the
presence of the inhibitors (60 min, 37 °C). Subsequent binding
sites were then measured using [3H]granisetron and expressed
as the percentage of binding in control cells (exposed to the
inhibitors but not 5-HT). Neither dynasore, nystatin, nor both
together block the loss of function caused by prolonged expo-
sure to 5-HT (p 0.05; ANOVA; Fig. 1B), suggesting that nei-
ther clathrin- nor caveolin-mediated endocytosis is required
for the reduction in binding sites observed.
To confirm a lack of involvement of receptor internalization,
we monitored cell surface receptor levels using an extracellular
epitope (HA) tag and whole cell ELISA. 5-HT3A-HA receptor-
expressing cells were incubated in the presence/absence of
5-HT (60 min, 37 °C) and fixed (3% paraformaldehyde) to pre-
vent further membrane trafficking, and the remaining surface
receptors were quantified by ELISA. Exposure to 5-HT (100M
or 1 mM) had no effect on cell surface receptor levels (112.6 
12.4 and 107.7 11.8%) compared with untreated cells (100
15.5%), respectively (p 0.05; ANOVA, n 3; Fig. 1C). Clearly,
the cell surface 5-HT3 receptor levels remained stable during
chronic exposure to high levels of 5-HT despite the presence of
a robust loss of surface binding sites (Fig. 1A). To further dem-
onstrate that receptor internalization does not occur, we per-
formed a fluorescence endocytosis assay to track surface recep-
tors. Cell surface receptors were labeled with an anti-HA
antibody (on ice) and then incubated (60 min, 37 °C) in the
presence of absence of 5-HT (300 M, 60 min). Receptors
remaining on the cell surface were identified using an Alexa
488-tagged secondary antibody ( det), cells were then per-
meabilized and reprobed using an Alexa 568 tagged secondary
antibody (	 det) to identify internalized receptors (Fig. 1D). In
support of the ELISA and use of endocytosis inhibitors, no
receptor internalization was observed.
A number of signaling eventsmediated by intracellular 5-HT
have been identified previously. These include serotonylation
(transglutaminase-mediated attachment of 5-HT to target pro-
teins) (29, 30), the formation of reactive oxygen species accom-
panied by ERK1/2 MAPK and tyrosine kinase activation (31),
5-HT3 Receptor Desensitization by Chronic 5-HT Exposure
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and the regulation of nitric oxide signaling (32). To investigate
potential roles for these events in the regulation of 5-HT3
receptors, a range of inhibitors was used. 5-HT3A-expressing
cells were preincubated for 60 min at 37 °C with each inhibitor,
and 5-HT (300 M) induced down-regulation monitored and
related to inhibitor only (no 5-HT) controls. The transglutami-
nase inhibitors cysteamine (CTA, 500 M) or dansylcadaverine
(DAN, 200 M), the antioxidants (used to inhibit reactive oxy-
gen species) vitamin C (VTC, 50 M) or tiron (TRN, 5 mM), the
ERK1/2 inhibitors PD98059 (10 M) or UO126 (10 M), the
tyrosine kinase inhibitor herbimycin A (2 M), or the nitric
oxide synthase (NOS) inhibitor L-NAME (NG-nitro-L-arginine
methyl ester, LNM, 1 mM) were without effect on the ability of
5-HT to down-regulate 5-HT3 binding sites (Fig. 1E; p 0.05,
ANOVA, n  4). These findings indicate that intracellular
5-HT signaling via previously identified pathways is not
required for 5-HT3 receptor loss of function.
Down-regulation of 5-HT3 Receptor Function in the Guinea
Pig Ileum—As high levels of 5-HT are observed within the gut,
we investigated whether chronic exposure to 5-HT led to a
ligand-induced down-regulation of receptor function in the
intact guinea pig ileum. Specific 5-HT3 receptor activation was
monitored by the contractile responses induced by the selective
agonist 2-ME. Acute exposure to 5-HT (100 M) caused a
robust contraction and rapid receptor desensitization (Fig. 2A,
center trace) which recovered quickly after washing (10 min,
not shown). In contrast, chronic exposure to 5-HT (100 M, 60
min), followed by washout in a drug-free buffer for 10 min (to
allow receptor resensitization) caused a significant decrease (to
48.6  25.0%, Fig. 2B) in the magnitude of subsequent 2-ME-
evoked contractions (p 0.001,ANOVA,n 28) (Fig. 2A, right
trace) compared with the pretreatment contraction (Fig. 2A,
left trace). After removal of 5-HT (60 min) the responses to
2-ME were fully recoverable (Fig. 2B). To investigate the spec-
ificity of the 5-HT3 functional loss, contractions evoked byACh
were also quantified. In this case the magnitude of ACh
responses were unaffected by chronic 5-HT treatment (p 
0.05; ANOVA, n 14; Fig. 2C), verifying that the tissuewas still
capable of undergoing contractions and that the down-regula-
tion was specific to 5-HT3 receptors. An individual example of
5-HT3 functional loss is shown (Fig. 2A) where a pre-pulse of
2-ME andAChprecedes 5-HT chronic (60min) exposure (note
early receptor desensitization). After the chronic exposure to
5-HT, 2-ME, but not ACh, responses were reduced.
To determine whether receptor internalization contributed
to the loss of 2-ME responsiveness in the ileum, dynasore (80
M) or nystatin (21 M) were co-applied with 5-HT during the
chronic exposure (60 min). Neither drug alone or in combina-
tion had a significant effect on 5-HT3 contractions or the sub-
sequent loss of responsiveness (p  0.05; ANOVA, n  8- 33;
Fig. 2D). Similarly, filipin (7.6M), an additional caveolin inhib-
itor, also failed to prevent the loss of 5-HT-mediated loss of
responsiveness (Fig. 2D). Together, these results suggest that
receptor internalization via clathrin- or caveolae-dependent
pathways is not responsible for the dynamic changes in 5-HT3
receptor-induced contractions that we observe in intact ileum
(Fig. 2) or loss of binding sites in COS-7 cells (Fig. 1).
5-HT3Down-regulation of Function Is Potentiated by SERT—
As extracellular 5-HT is rapidly sequestered by the SERT trans-
porter, we investigated whether this loss could be influenced by
the cellular influx of 5-HT. Therefore, we investigated the
impact of human SERT co-expression with the receptor
FIGURE 1. Chronic exposure to 5-HT decreases 5-HT3 receptor [
3H]granisetron binding sites in COS-7 cells through endocytosis-independent mech-
anisms.A, binding sitesmeasured after chronic 5-HT exposure (300M, 60min, 37 °C) or untreated control (UT). Data represent an average of five experiments
performed in triplicate. *** signifies p 0.001, paired t test. B, normalized (to untreated) binding sites measured after chronic 5-HT exposure (300M, 60min,
37 °C) in the presence of 80 M dynasore (DYN), 21 M nystatin (NYS), and both dynasore and nystatin. Data represent an average of three experiments
performed in triplicate. C, ELISAmeasuring cell surface expression of 5-HT3A-HA after chronic exposure to 5-HT (300Mor 1mM, 60min, 37 °C). Data represent
an average of three experiments performed in triplicate.D, immunofluorescence detection of surface (no detergent ( det)) receptors in the absence (5-HT)
or presence (	 5-HT) of 5-HT. E, the effect of key signaling pathways on down-regulation investigated in 5-HT3A and SERT co-expressing cells. Cells were
incubated (60min, 37 °C) with no drugs or 5-HT (5-HT), no drug with 300M 5-HT (	5-HT), or one of the following drugs (present before (60min, 37 °C) and
during 5-HT (300M, 60min) treatment): cysteamine (CTA, 500M), dansylcadaverine (DAN, 200M), vitamin C (VTC, 50M), tiron (TRN, 5 mM), PD98059 (PD9,
10 M), UO126 (UO1, 10 M), herbimycin A (HRB, 2 M) or L-NAME (NG-nitro-L-arginine methyl ester (LNM), 1 mM). Cells were washed (10 min, 37 °C) before
monitoring the remaining binding sites with [3H]granisetron. Data represent an average of three or four experiments performed in triplicate.
5-HT3 Receptor Desensitization by Chronic 5-HT Exposure
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(equimolar cDNA ratios). Cells were incubated with a range of
concentrations of 5-HT (60min, 37 °C), and the remaining sur-
face receptor binding sites were determined by [3H]granisetron
binding (Fig. 3A). Regardless of the presence of SERT, chronic
5-HT exposure caused a concentration-dependent decrease in
receptor binding sites. Cells expressing 5-HT3A alone required
a high concentration to cause a subsequent inhibition of bind-
ing, with an IC50 of 154.0  45.7 M, and complete loss was
observed at
1mM5-HT. In contrast, cells co-expressing SERT
aremore sensitive to 5-HTexposure, exhibiting an IC50 of 2.3
1.0 M (a 67-fold enhancement by SERT), and complete inhi-
bition occurred at
10 M (Fig. 3A).
As SERT increases the potency of 5-HT-induced down-reg-
ulation, we also investigated its effect on the kinetics of func-
tional loss. Cells expressing 5-HT3A in the presence or absence
of SERT were exposed to 100 M 5-HT, and surface binding
sites were monitored over time with [3H]granisetron (Fig. 3B).
A time-dependent reduction in receptor binding sites were
observed, with a markedly faster rate was observed in SERT-
expressing cells (t1⁄2  3.4 min) compared with those without
SERT (t1⁄2 28.6 min). Taken together, these findings indicate
that the loss of surface receptor binding sites is related to the
level of cellular uptake of 5-HT.
SERTFunction Is Required for Its Potentiating Effect on 5-HT-
mediated Loss of Function—Given the potentiation of down-
regulation by SERT, we investigated whether SERT function is
required. 5-HT3A and SERT co-expressing cells were preincu-
bated with the SERT inhibitor, fluoxetine (10 M, 10 min,
37 °C), before exposure to 5-HT (3 M, 60 min, 37 °C) in the
continued presence of fluoxetine (Fig. 3C). In keeping with a
requirement 5-HT influx, fluoxetine completely blocked the
loss of function (103.98 10.84% of untreated, p 0.05; Mann
Whitney test). In contrast, in cells in which SERT was not
expressed, fluoxetine did not block down-regulation to 5-HT (1
mM) (not shown).
To confirm 5-HT cellular uptake, we monitored 5-[3H]HT
accumulation. Cells were incubated with 5-[3H]HT (1 or 100
M) for 60 min at 37 °C and washed, and cell-retained
5-[3H]HT was counted. As expected, SERT-expressing cells
demonstrated a robust concentration-dependent uptake of
5-[3H]HT (Fig. 3D). In contrast, in cells lacking SERT expres-
sion, 5-[3H]HT uptake was only detected at 100 M (Fig. 3D).
FIGURE 2. 5-HT3 down-regulation of function in the guinea pig ileum occurs through endocytosis-independent mechanisms. A, sample trace of an
organbath experiment investigating the chronic effects of 5-HT.Dots represent brief exposure timeswhereby the indicateddrugwaswashedout immediately
after maximal contraction obtained. The arrow indicates prolonged (60 min) exposure with no washout. B, the contractile responses to 2-ME (50 M) were
measured in the tissue (Initial). After 60minof exposure to100M5-HT (followedby10minwashout), the resultant 2-ME responsesweremeasured (post-5-HT).
2-ME responses were also tested 60 min post treatment to monitor long term recovery. Data represent an average of 28 independent tissue samples. ***
signifies p 0.001 (ANOVA). C, responses to 1MAChbefore and after 5-HT treatment (60min) and after a 60-min recovery in drug-free buffer. Data represent
an averageof 14 sections of tissue.D, tissue responses to 2-ME (50M) after chronic exposure to 5-HT (100M, 60min) in the absence andpresenceof dynasore
(DYN; 80 M), nystatin (NYS; 21 M), dynasore plus nystatin, or filipin (FLP; 7.6 M). Data are an average of 8–33 sections of ileum.
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The concentration-dependent effects (IC50 2.3 (	 SERT) or
154 M (SERT) (Fig. 3A) on down-regulation are consistent
with a requirement for intracellular 5-HT transport.
Cytoplasmic 5-HT Is Required to Inhibit 5-HT3 Receptor
Binding—To gain further insight into a potential mechanism of
action, we investigated whether transported 5-[3H]HT was
associated with cellularmembranes or remained soluble within
the cytoplasm. Cells were incubated with 5-HT (10 M, 10% of
which was 5-[3H]HT) in Opti-MEM for 60 min at 37 °C, and
cells were washed with binding buffer before being solubilized
with 1%TX-114 (5min, 4 °C). Radioactivity associated with the
membrane phase and each sequential wash (cytosol) was
counted (Fig. 4A). In keepingwith previous observations, where
cells lacking SERT exhibited little cellular uptake (Fig. 3D) and
no loss of function (Fig. 3A) at this concentration of 5-HT, we
found no significant intracellular 5-[3H]HT accumulation (Fig.
4A). In SERT-expressing cells (regardless of 5-HT3 receptor
expression), robust counts were detected in the first cytosolic
fraction (wash 1), with diminishing counts associated with sub-
sequent washes. Minimal 5-[3H]HT remained in the final
TX-114membrane fraction, suggesting that intracellular 5-HT
is predominantly freely soluble. Importantly, in cells co-ex-
pressing SERT and 5-HT3A receptors, no increased cellular
retention or membrane association was observed. Therefore,
prolonged receptor association through a putative intracellular
binding site is not responsible. Moreover, in our assays, 5-HT
(10 M) does not exhibit prolonged 5-HT3 receptor binding, as
no 5-[3H]HT binding (Fig. 4B, total) was observed above the
nonspecific binding (as determined by competition with excess
ondansetron) after rapid washing in 5-HT3A-transfected cells.
To confirm that SERT-mediated 5-HT accumulation is read-
ily releasable from cells, we used digitonin to permeabilize the
cells and release the cytoplasmic contents. Cells were loaded
with 10M5-HT as above, and excess 5-HTwas removed. Cells
were then chilled on ice and incubated with digitonin (100
g/ml in binding buffer) for 5 min on ice. The released (3 con-
secutive washes pooled) and cell-associated (solubilized in 1%
TX-100) 5-[3H]HT was counted. In cells expressing 5-HT3A
receptors alone, no detectable 5-HT accumulation was de-
tected (Fig. 4C) consistent with previous experiments. In cells
expressing SERT alone, the majority of counts (79.1  3.3%
total) were detected in the cytoplasmic phase. Similarly, in cells
co-expressing SERTand 5-HT3A receptors, 80.0 3.0%of total
countswere in the cytoplasmic phase. Although a proportion of
the 5-HT remains associated with the cells, this is not bound to
the receptors, as the levels of cell-associated counts are not
increased by 5-HT3 receptor expression.
To distinguish between a cytoplasmic role for 5-HT from any
consequential effects following its subsequent release fromcells
(extracellular effects), we investigated whether the co-expres-
sion of SERT within the same cell is required. Therefore, we
compared the down-regulation responses to low 5-HT (10 M)
in a population of cells co-expressing the receptor and trans-
porter with a mixture of two populations of cells, one express-
ing the receptor only and the other expressing only the trans-
porter. A cytoplasmic function of 5-HT would be potentiated
by SERT only if it is co-expressed on the same cells. In contrast,
an extracellular effect would also occur if SERT expression was
limited to neighboring cells.
FIGURE 3. SERT potentiates 5-HT-mediated down-regulation of 5-HT3 receptor function in COS-7 cells. A, concentration-response to [
3H]granisetron
(Gran) binding site availability after chronic 5-HT exposure (60 min, 37 °C) to cells expressing 5-HT3A (filled circles, solid line) or 5-HT3A and SERT (open circles,
dashed line). Data represent an average of 3–4 experiments and are fitted to a sigmoidal dose-response curve (variable slope) function. UT, untreated control.
B, time-course of 5-HT (100M) induced down-regulation in 5-HT3A (filled circles, solid line) or 5-HT3A and SERT-expressing cells (open circles, dashed line). Data
represent the averageof threeexperimentsperformed in triplicate andareplottedusing theone-phaseexponential decay function.C, [3H]granisetronbinding
sitesmeasured after chronic exposure to 5-HT (3M, 60min, 37 °C) in the absence (UT) or presence of fluoxetine (FLX, 10M) in 5-HT3A and SERT co-expressing
cells. *** signifies p 0.05; Mann Whitney test. D, 5-HT (5-[3H]HT) uptake into COS-7 cells in the absence (SERT) or presence (	SERT) of SERT expression.
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As shown previously (Fig. 3A), when 5-HT3 and SERT are
co-expressed, low 5-HT (10 M) is sufficient to induce down-
regulation (Fig. 4D, 3A 	 SERT cotransfection). When inde-
pendent cell populations expressing either 5-HT3 receptors or
SERT were mixed after transfection (Fig. 4D, 3A/SERT com-
bined), the loss of binding sites was still induced by low 5-HT.
This indicates that the potentiation of down-regulation seen by
SERT does not require 5-HT transport into the same cells
expressing the 5-HT3 receptors. Therefore, the cytoplasmic
pool of 5-HT may provide a reservoir from which subsequent
5-HT release may influence 5-HT3 receptor function.
5-HT Release and Inhibition of Receptor Resensitization—To
determine if cells are capable of releasing the sequestered 5-HT,
we investigated the release of 5-[3H]HT from COS-7 cells and
the guinea pig ileum. COS-7 cells (no SERT) were loaded with
5-HT (300 M, 0.1% 5-[3H]HT, 60 min), excess 5-HT was
washed off, and cells were chased for 120min. Under the exper-
imental conditions in which we observed down-regulation of
function (Figs. 1 and 3), the release of 5-HT reached lowmicro-
molar levels (Fig. 5A). To determine if the same pool of 5-HT
exists within cells in native tissue where high 5-HT level can
occur, we investigated 5-HTuptake (300M, 0.1% 3H-5-HT, 60
min) in guinea pig ileum segments. A 7-cm segment was turned
inside out and incubated with 5-HT (100 M, 0.16% 3H-5-HT,
60 min). Five equal sections were cut, and 5-HT release was
monitored (in 1.5ml) from each. Under these conditions, 5-HT
is sequestered and released from the ileum in the lowmicromo-
lar range (Fig. 5B).
In COS-7 cells expressing SERT, 5M 5-HTwas sufficient to
cause significant loss of function (IC50 2.3). However, in the
absence of SERT it exerted little effect (IC50 154 M) on 5-HT3
receptor function (Fig. 3A). Therefore, we investigatedwhether
sustained low concentrations of 5-HT might inhibit receptor
resensitization. Therefore, guinea pig ileum segmentswere first
validated for contractile responses (1 M ACh) (not shown),
and themagnitude of 2-ME (50M) responses was determined.
After recovery to base line, 5-HT (100 M) was then applied
until full desensitization occurred. Recovery from desensitiza-
tion of 5-HT3 receptors was then monitored (50 M 2-ME)
after 10 min in the absence of 5-HT, where recovery (82.5 
21.8%) occurred (Fig. 5, C and D). However, in the presence of
5-HT (5 M), no recovery (0.9  0.9%) occurred (p  0.0014,
paired t test, 2 tailed, n  4). Therefore, chronic exposure to
high levels of 5-HT leads to receptor desensitization and local
5-HT sequestration followed by a subsequent slow release of
5-HT that inhibits 5-HT3 receptor resensitization.
DISCUSSION
Dynamic ligand-induced regulation of 5-HT3 receptors is
likely to have relevance to a number of (patho)physiological
FIGURE4.Cytosolic accumulationof5-HTcorrelateswith the lossof receptorbindingsites.A, cells expressing5-HT3A, SERT, or 5-HT3A	SERTwere loaded
with 10M 5-HT (10% 5-[3H]HT) for 60min at 37 °C. Postnuclear cytosolic (TX-114 supernatant at 37 °C) fractions were counted (wash 1). Themembrane pellet
washed (wash2and3) and remainingmembranepellet fraction (TX-114)were counted.Data represent anaverageof threeexperimentsperformed in triplicate.
B, 5-HT3A-expressing cells were incubatedwith 10M 5-[
3H]HTwith (nonspecific binding (NSB)) or without (total) 10M ondansetron (60min at 37 °C). C, cells
expressing 5-HT3A, SERT, or both were incubated with 10 M 5-HT (10% 5-[
3H]HT) for 60 min at 37 °C. Cells were permeabilized with digitonin (100 g/ml) to
release cytosolic 5-HT and compared with cell-associated signal. Data represent an average of three experiments performed in triplicate. D, cells expressing
5-HT3A only (3A), 5-HT3A and SERT (3A 	 SERT cotransfection), or cells expressing either 5-HT3A or SERT and subsequently mixed (3A/SERT combined) were
examined for 5-HT (10 M or 1 mM, 60 min, 37 °C)-induced down-regulation of receptor binding sites ([3H]granisetron (Gran)). UT, untreated.
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situations characterized by changes in 5-HT levels. Here we
report that with recombinantly expressed human 5-HT3 recep-
tors and in the intact guinea pig ileum, chronic exposure to
5-HT caused a transient down-regulation of receptor function.
In both cases we showed that this loss occurs independently of
receptor endocytosis. Intriguingly, we found that intracellular
5-HT sequestration plays an important role, and this was sup-
ported by potentiation by SERT. However, this was not due to
serotonylation or known signaling pathways. These findings
offer a novel regulatory mechanism by which 5-HT3 receptors
may be modulated by their endogenous ligand after circum-
stances of chronic exposure.
Agonist-mediated down-regulation of 5-HT3 receptors has
been reported in a number of settings (17, 21). We corroborate
these findings by demonstrating that chronic exposure to 5-HT
can reduce 5-HT3 receptor binding sites in a recombinant
expression system and mediate a loss of 5-HT3 receptor-in-
duced contractility in the intact ileum.
Previous reports have suggested a reduction in cell surface
receptor numbers through internalization as a mechanism for
agonist-mediated down-regulation (17, 18). However, we
directly tested the role of receptor endocytosis and present
clear evidence that down-regulation is insensitive to inhibitors
of endocytosis and demonstrated that no internalization or
changes in cell surface receptor levels occur.
It is possible that species difference is responsible for the
distinct findings observed previously. We have investigated
human (recombinant) and guinea pig receptors, whereas previ-
ous studies have focused on mouse (18) or rat (17) receptors.
Similarly, we have used COS-7 cells or intact ileum, whereas
HEK293 cells (18) or enteric neurons (17) were investigated
previously. However, much of the data presented by both
groups can be explained by a loss of receptor binding sites. In
one study (18), 5-HT was not used as the agonist, and ligand-
specific effects are possible.
An alternative mechanism is slowed dissociation kinetics of
5-HT. Indeed we have demonstrated recently that the clinically
used 5-HT3 receptor antagonists palonosetron and ondanse-
tron chronically down-regulate 5-HT3 receptors via prolonged
receptor binding (22). However, we do not find prolonged
interactions of 5-HT with receptors or any other cellular tar-
gets. Indeed, relative to its acute effects (EC50 
 6 M) (48) at
5-HT3A receptors, supramaximal concentrations of 5-HT
(IC50 154 M) are required to produce down-regulation (in the
absence of SERT expression), suggesting amechanismof action
independent of its acute binding to the orthosteric receptor
binding site. However, when cellular uptake of 5-HT is
increased by SERT coexpression, the potency and kinetics of 5-
HT-induced down-regulation is increased accordingly. There-
fore, contrary to previous interpretations and alternativemech-
anisms, we propose that during periods of high 5-HT levels,
cellular sequestration occurs, and this provides a reserve pool of
5-HT from which a constant unregulated release occurs. By
mimicking our experimental release of 5HT observed during
our cellular studies, we show that low levels of 5-HT prevent
FIGURE5.5-HT releaseand its impacton receptor resensitization.A, time courseof 5-HT release fromCOS-7 cells after loading (300M5-HT (0.1%5-[3H]HT),
1 h). B, time course of 5-HT released from segments of adult guinea pig ileum following loading (100M5-HT (0.1%5-[3H]HT), 1 h). Data represent 20 segments
of ileum from 4 different animals. C, 5-HT3 receptor resensitization in adult guinea pig ileum. Acute exposure to 5-HT (100 M) was applied until full receptor
desensitization observed and 5-HT3 receptor contractions (50 M 2-ME) were determined after a 10-min resensitization period in the absence (5-HT) or
presence (	5-HT) of 5M5-HT.Data represent 12 segmentsof ileum for eachexperimenton3 separateoccasions. *** signifiesp0.0014 (paired t test, 2 tailed,
n 4).D, representative traces of guinea pig contractions indicating initial responses to ACh, 2-ME, and 5-HT (left traces) and subsequent 2-ME and ACh (right
traces) responses after receptor desensitization to 5-HT (100 M,1 min) and subsequent recovery in the absence (upper panel) or presence (lower panel) of
5-HT (5 M). Each panel (upper or lower) represents traces from a single continuous experiment.
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recovery from receptor desensitization of 5-HT3 receptors in
the guinea pig ileum.
Therefore, we propose that low levels of 5-HT may cause
receptor desensitization (33) but not down-regulation, as insuf-
ficient 5-HT is sequestered, and receptors recovery rapidly on
the removal of 5-HT. In contrast, at higher levels or in the vicin-
ity of SERT expression, 5-HT sequestrationmay be sufficient to
result in a prolonged release of 5-HT at low level that is suffi-
cient to prevent receptor resensitization. 5-HT release plateaus
in the closed large volume systems used here (COS-7 cells or
guinea pig ileum) suggesting an equilibrium is reached. The
physiological relevance of our observations of 5-HT-mediated
regulation of 5-HT3 receptors will depend on the duration and
concentration of endogenous 5-HT exposure, the local expres-
sion of SERT, and the opportunity for diffusion away from the
site of release. Under basal conditions, 5-HT release from the
rat ileum is
6 M, peaking to 16 M upon mechanical stimu-
lation (34). These levels are increased somewhat when rats are
fed a Western style high fat and high calorie diet (27). Plasma
5-HT concentrations in healthy individuals have been observed
at tens of nanomolar, with increases of up to an order of mag-
nitude in patients with irritable bowel syndrome with diarrhea,
complex regional pain syndrome, depressive disorders, autism,
or coronary artery disease (25, 26, 35, 36). Emesis caused by
cancer therapy has been linked to increased 5-HT release from
enterochromaffin cells in the gut (37). Moreover a robust and
prolonged (over many hours) increase in 5-HT release from
enterochromaffin cells linked to emesis has been reported after
exposure to viral toxins (38). 5-HT3 receptor desensitization
following a chronic 5-HT exposure eventmay protect the intes-
tinal tract from mucositis as shown for receptor antagonism
during 5-fluoruracil chemotherapy (39).
In the gut 5-HT3 receptors are postsynaptically expressed on
sensory nerve endings and on interneurons of the enteric ner-
vous system (40) and on non-neuronal enterochromaffin cells
(41) where they make an important contribution to contrac-
tion. SERT is expressed in the mucosal epithelium as well as on
serotonergic neurons but not on enterochromaffin cells (42,
43), and there is little direct evidence to suggest co-expression
of 5-HT3 receptors and SERT within the same cells in the gut.
However, we demonstrate that SERT co-expression in the same
cells is not required and SERT-independent 5-HT uptake
mechanisms exist (44, 45). Beyond the gut, 5-HT3 receptors and
SERT are co-expressed within the same presynaptic cells in the
solitary tract (46). Moreover, platelets, lymphocytes (B-cells),
dendritic cells, glial cells, and sperm have also been reported to
express both 5-HT3 receptors and SERT (46–49). Therefore,
there is potential for 5-HT-mediated regulation of 5-HT3
receptors at physiologically relevant levels in the CNS, the
blood, the immune system, and the reproductive system.
The pharmacotherapeutic use of selective serotonin re-
uptake inhibitors or the recreational use of drugs targeting
SERT (such as cocaine, MDMA (3,4-methylenedioxy-N-meth-
ylamphetamine) and amphetamines) may also impact 5-HT3
desensitization by increasing 5-HT levels. To add further com-
plexity to 5-HT3 receptor signaling, 5-HT can also regulate the
function and expression of SERTor influence presynaptic auto-
receptors (5-HT3/5-HT4) that modulate 5-HT release. There-
fore, reciprocal cross-regulation of 5-HT3 and SERTmay act to
finely tune serotonergic signaling.
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